Seoul National University Hospital
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 501
- Market Cap
- -
- Website
- https://www.snubh.org
Study on Prediction of Fluid Responsiveness Using an Abdominal Compression-induced Change of Blood Pressure in Children
Not Applicable
Completed
- Conditions
- Hypovolemia
- Interventions
- Procedure: abdominal compression
- First Posted Date
- 2015-06-15
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT02471534
- Locations
- π°π·
Seoul national university hospital, Seoul, Korea, Republic of
Desflurane in Children With Laryngeal Mask Airway
Not Applicable
Completed
- Conditions
- Desflurane Anesthesia
- Interventions
- Drug: Sevoflurane/DesfluraneDrug: Sevoflurane
- First Posted Date
- 2015-06-12
- Last Posted Date
- 2017-08-04
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT02470442
- Locations
- π°π·
Seoul national university hospital, Seoul, Korea, Republic of
Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis
Phase 2
- Conditions
- Takayasu's Arteritis
- Interventions
- First Posted Date
- 2015-05-29
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 11
- Registration Number
- NCT02457585
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Gastric Cancer Screening Quality Improvement System Establishment
- Conditions
- Intestinal MetaplasiaGastric CancerGastritis, Atrophic
- Interventions
- Behavioral: Education and feedback
- First Posted Date
- 2015-05-29
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 17
- Registration Number
- NCT02457624
- Locations
- π°π·
Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea, Republic of
Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts
Not Applicable
Completed
- Conditions
- Latent Tuberculosis
- Interventions
- Radiation: Ultralow dose chest CT scan
- First Posted Date
- 2015-05-27
- Last Posted Date
- 2016-06-07
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 6
- Registration Number
- NCT02454738
- Locations
- π°π·
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
Treatment of Refractory Auditory Verbal Hallucinations With tDCS in Schizophrenia
Phase 1
Completed
- Conditions
- Schizophrenia
- Interventions
- Device: tDCS
- First Posted Date
- 2015-05-22
- Last Posted Date
- 2016-12-30
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT02451371
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Pharmacokinetics of Co-administration of Seretide 250 Diskus (HCP0910) and Spiriva Capsule for Inhalation (HGP1011)
Phase 1
Completed
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Drug: HCP0910 and HGP1011
- First Posted Date
- 2015-05-12
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT02441114
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia
- First Posted Date
- 2015-05-12
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 66
- Registration Number
- NCT02440178
Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer
- Conditions
- Prostate NeoplasmPathology
- First Posted Date
- 2015-05-06
- Last Posted Date
- 2015-05-19
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 264
- Registration Number
- NCT02436122
- Locations
- π°π·
Seoul National University Bundang Hospital, Seongnam-si, Kyunggi-do, Korea, Republic of
Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer
Phase 2
Completed
- Conditions
- Biliary Tract Cancer
- Interventions
- Drug: TH-302 monotherapy
- First Posted Date
- 2015-05-05
- Last Posted Date
- 2018-09-10
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT02433639
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath